| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 736780 | (2Z,4E)-2-cyano-5-[4-(diethylamino)phenyl]penta-2,4-dienethi oamide | 0.00910228844192553 | 0.33064832 |
| NSC 743874 | Null | 0.00910228844192553 | 0.41582027 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0091022884419256 | 0.35906507 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0091022884419256 | 0.048469739 |
| NSC 135073 | WITHACNISTIN | 0.0091022884419256 | 0.64622729 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.0091022884419256 | 0.60799849 |
| NSC 276361 | 1H-Pyrrole-3,4-dimethanol, 1-(4-butylphenyl)-2,5-dimethyl-, bis(methylcarbamate) (ester) | 0.0091022884419256 | 0.12640725 |
| NSC 603084 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- | 0.0091022884419256 | 0.61269199 |
| NSC 618770 | Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide | 0.0091022884419256 | 0.51050562 |
| NSC 623166 | Null | 0.0091022884419256 | 0.43923753 |